S-4 - Talaris Therapeutics, Inc. (0001827506) (Filer)

1 min to read

S-4 – Talaris Therapeutics, Inc. (0001827506) (Filer)

Filed: 2023-07-20 AccNo: 0001193125-23-189834 Size: 9 MB
Source: S-4 – Talaris Therapeutics, Inc. (0001827506) (Filer)

Tags: SEC

Berenson Acquisition I Signs NRA Ahead of Extension Vote

Berenson Acquisition I in an 8-K said it entered into a non-redemption agreement with one or more unaffiliated third parties in exchange for...
VAM Investments SPAC B : Press Release – Interim Financial … – Marketscreener.com

VAM Investments SPAC B : Press Release – Interim Financial ... Marketscreener.com Source: VAM Investments SPAC B : Press Release –...
Welsbach Technology Metals Acquisition Postpones Extension Vote 24 Hours

Welsbach Technology Metals Acquisition today said the Sept. 28 meeting for shareholders to vote on a deadline extension has been...
Athena Consumer Acquisition Corp. Announces Intention to Voluntarily Delist from NYSE American LLC and Planned Listing by Post-Combination Company on Nasdaq Upon Consummation of its Pending Business Combination with Next.e.GO Mobile SE – Yahoo Finance

Athena Consumer Acquisition Corp. Announces Intention to Voluntarily Delist from NYSE American LLC and Planned Listing by Post-Combination Company on...
Network security company IronNet ceases operations two years after … – SiliconANGLE News

Network security company IronNet ceases operations two years after ... SiliconANGLE News Source: Network security company IronNet ceases operations two years...